Update on emerging infections: News from the centers for disease control and prevention

Annals of Emergency Medicine

Volumn 45, Issue 3, 2005, Pages 323-326

  Ufberg, Jacob W ^a   Karras, David J ^a   Talan, David A ^b   Moran, Gregory J ^b   Pinner, Robert ^c  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; RIBAVIRIN;

CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; EBOLA VIRUS; EMERGENCY MEDICINE; HOSPITALIZATION; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION CONTROL; INFECTION PREVENTION; LABORATORY TEST; LASSA FEVER; LASSA VIRUS; MALARIA; MARBURG VIRUS; NONHUMAN; NOTE; PRIORITY JOURNAL; PUBLIC HEALTH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; TYPHOID FEVER; VIRUS HEMORRHAGIC FEVER; YELLOW FEVER;

EID: 13844310154     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2004.12.015     Document Type: Note

References (4)

1. CDC Lassa fever fact sheet 2004 US Department of Health and Human Services, CDC Atlanta, GA Available at: http://www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/lassaf.htm
2. K.M. Johnson T.P. Monath Imported Lassa fever—reexamining the algorithms N Engl J Med 323 1990 1139 1141
3. G.P. Holmes J.B. McCormick S.C. Trock Lassa fever in the United States: investigation of a case and new guidelines for management N Engl J Med 323 1990 1120 1123
4. W.H. Haas T. Breuer G. Pfaff Imported Lassa fever in Germany: surveillance and management of contact persons Clin Infect Dis 36 2003 1254 1258